Head and Neck Adenocarcinoma — Trials

Head and Neck Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 19
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 151–200 of 213 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04695015	Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm	unknown	—	100	Peking UniversityOTHER	0	Jan 5, 2021	clinicaltrials
NCT02138214	Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer	completed	Phase 2	117	University of Wisconsin, MadisonOTHER	1	Dec 21, 2020	clinicaltrials